Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,633 | 40,544 | 33,720 | 5,646 | 17,350 |
| Marketable Securities | 105,357 | 53,076 | 18,906 | 8,034 | 12,863 |
| Receivables | 7,333 | 2,804 | 3,302 | 867 | 506 |
| Income taxes - deferred | N/A | 343 | 62 | 63 | N/A |
| TOTAL | $171,851 | $98,947 | $58,684 | $15,968 | $31,907 |
| Non-Current Assets | |||||
| PPE Net | 7,307 | 4,583 | 2,887 | 363 | 296 |
| Investments And Advances | 19,993 | 12,891 | 10,483 | 11,071 | 9,272 |
| Intangibles | 14,019 | 14,890 | 15,832 | 17,603 | 19,424 |
| Other Non-Current Assets | 671 | 475 | 402 | 134 | 208 |
| TOTAL | $41,990 | $32,838 | $29,604 | $29,171 | $29,200 |
| Total Assets | $213,841 | $131,785 | $88,287 | $45,139 | $61,107 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,230 | 6,412 | 5,967 | 3,369 | 4,339 |
| Accrued Expenses | 2,601 | 2,007 | 1,446 | 1,406 | 1,059 |
| Other current liabilities | 1,301 | 2,023 | 19,541 | 2,860 | 5,176 |
| TOTAL | $31,466 | $14,085 | $28,967 | $8,377 | $11,043 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 14,335 | 3,644 | 2,013 | 742 | 468 |
| Other Non-Current Liabilities | -85 | 18 | 55 | 44 | 51 |
| TOTAL | $6,441 | $6,162 | $6,418 | $1,905 | $2,202 |
| Total Liabilities | $37,908 | $20,248 | $35,385 | $10,281 | $13,245 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,016 | 5,060 | 4,990 | 3,747 | 2,811 |
| Common Shares | 72 | 61 | 53 | 144 | 135 |
| Retained earnings | -361,098 | -331,910 | -295,789 | -229,760 | -210,091 |
| Other shareholders' equity | 2,954 | 59 | 371 | 576 | 582 |
| TOTAL | $175,933 | $111,538 | $52,903 | $34,857 | $47,862 |
| Total Liabilities And Equity | $213,841 | $131,785 | $88,287 | $45,139 | $61,107 |